Bridgewater based health care company Sanofi announced three appointments to key leadership roles Aug. 3 for its U.S. General Medicines, North American Vaccines and Consumer Healthcare businesses.
Olivier Bogillot will assume the role leading U.S. General Medicines, specifically serving the diabetes, cardiovascular and transplant communities, on Sept. 1.
Bogillot joined Sanofi in 2015 and has held roles including executive director of global policy based in the U.S. AND chief of staff to the CEO. In March 2020, he was appointed president of Sanofi France. Bogillot held roles in at Merck KGaA, Amgen and Bristol-Myers Squibb before being appointed chief of staff to the director at the Greater Paris Regional Health Agency in 2009. He joined the presidency in France in 2011 as advisor for health, dependency, and social policies.
Deborah Glasser is the new head of vaccines in North America, effective June 20. Prior to joining the company, she spent 13 years at Biogen in the company’s U.S., European and global organizations, most recently as senior vice president for the U.S. Alzheimer’s Franchise. Prior to that, she was global vice president and asset lead for Biogen’s spinal muscular atrophy portfolio, global commercial lead for Alzheimer’s, and head of global marketing for biosimilars.
Andrew Loucks will assume the role of head of North America Consumer Healthcare, effective Aug. 8. He joins Sanofi from Boston-based consumer health and technology company Sensory Cloud Inc. where he was CEO and a board member.
Prior to Sensory Cloud, Loucks was president of Keurig Appliances and Away From Home Coffee Systems and a member of the Keurig Dr Pepper Executive Leadership Team. Before joining Keurig Dr Pepper, Loucks was president of frozen foods at Kellogg Co., where he was a member of the global leadership and North American leadership teams, and previously served as vice president of marketing, innovation and nutrition for Kellogg Canada.
Bogillot, Glasser and Loucks will join Sanofi’s U.S. Country Council, which will continue to be led by Carole Huntsman, head of specialty care North America and U.S. country lead.
